[go: up one dir, main page]

AU2313899A - Methods and compositions for treating and diagnosing insulin related disorders - Google Patents

Methods and compositions for treating and diagnosing insulin related disorders Download PDF

Info

Publication number
AU2313899A
AU2313899A AU23138/99A AU2313899A AU2313899A AU 2313899 A AU2313899 A AU 2313899A AU 23138/99 A AU23138/99 A AU 23138/99A AU 2313899 A AU2313899 A AU 2313899A AU 2313899 A AU2313899 A AU 2313899A
Authority
AU
Australia
Prior art keywords
insulin
degrading enzyme
polypeptide
complex
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23138/99A
Other languages
English (en)
Inventor
William Clifford Duckworth
Frederick G. Hamel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2313899A publication Critical patent/AU2313899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU23138/99A 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin related disorders Abandoned AU2313899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7082198P 1998-01-08 1998-01-08
US60070821 1998-01-08
PCT/US1999/000471 WO1999035169A2 (fr) 1998-01-08 1999-01-08 Methodes et compositions permettant de traiter et de diagnostiquer les troubles lies a l'insuline

Publications (1)

Publication Number Publication Date
AU2313899A true AU2313899A (en) 1999-07-26

Family

ID=22097585

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23138/99A Abandoned AU2313899A (en) 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin related disorders

Country Status (7)

Country Link
EP (1) EP1045860A2 (fr)
JP (1) JP2002500234A (fr)
CN (1) CN1292798A (fr)
AU (1) AU2313899A (fr)
BR (1) BR9906833A (fr)
CA (1) CA2317674A1 (fr)
WO (1) WO1999035169A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465714B2 (en) * 1999-11-05 2002-10-15 Arexis Ab Congenic animal models of non-insulin dependent diabetes mellitus
WO2006132530A2 (fr) * 2005-01-31 2006-12-14 Leiden University Medical Center Methodes et moyens a utiliser dans le diagnostic et le traitement de diabetes
WO2010049180A1 (fr) * 2008-10-31 2010-05-06 B.R.A.H.M.S. Ag Procédés et dosages pour la classification des denrées alimentaires et/ou des boissons et/ou des régimes alimentaires et/ou des traitements nutritionnels et/ou des médicaments, concernant leur effet sur le système cardio-vasculaire
CN102369015A (zh) * 2009-02-02 2012-03-07 雷蒙特亚特特拉维夫大学有限公司 肽、包含该肽的药物组合物及其用途
EP2600885A2 (fr) 2010-08-04 2013-06-12 Ramot at Tel Aviv University, Ltd. Procédés de traitement de maladies auto-immunes du système nerveux central (snc) et de maladies neurodégénératives
CN104961706B (zh) * 2015-07-06 2017-03-01 成都知普莱生物医药科技有限公司 一种合成胰岛素降解酶抑制剂ml345的方法
CN115477686B (zh) * 2022-09-22 2024-01-30 北海黑珍珠海洋生物科技有限公司 一种具有美白功效的珍珠贝活性肽及其应用
CN119322179B (zh) * 2024-09-03 2025-11-11 中日友好医院(中日友好临床医学研究所) 生物标志物在预测糖尿病强化治疗效果中的应用、试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891435A (en) * 1993-04-16 1999-04-06 Research Corporation Technologies, Inc. Methods and compositions for delaying or preventing the onset of autoimmune disease
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US5594100A (en) * 1995-02-22 1997-01-14 Regents Of The University Of Colorado Epitope for prevention of type I diabetes

Also Published As

Publication number Publication date
CA2317674A1 (fr) 1999-07-15
CN1292798A (zh) 2001-04-25
EP1045860A2 (fr) 2000-10-25
WO1999035169A2 (fr) 1999-07-15
WO1999035169A3 (fr) 1999-10-07
JP2002500234A (ja) 2002-01-08
BR9906833A (pt) 2001-11-27
WO1999035169A9 (fr) 1999-11-11

Similar Documents

Publication Publication Date Title
JP2828250B2 (ja) 真性糖尿病の治療
Scrocchi et al. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis
JP2961708B2 (ja) 成長ホルモンとインスリン様成長因子―１の組み合わせが成長を増進する
US5811395A (en) Relaxin analogs and derivatives methods and uses thereof
Clemmons Structural and functional analysis of insulin-like growth factors
JP5240586B2 (ja) 糖尿病性合併症治療用薬学的組成物
DE69736129T2 (de) Verfahren und Zusammensetzungen für die Behandlung von neoplastichen Krankheiten
EP2229952B1 (fr) Peptide plasmatique anti-diabétique NUCB2 (pladin et nesfatin-1) et ses utilisations
EP1435986B1 (fr) Peptide derive de proteines de liaison de l'igf
Szelke et al. H-77: a potent new renin inhibitor. In vitro and in vivo studies.
MX2008015657A (es) Polipeptidos de factor de crecimiento similares a insulina estabilizados.
JP2004520345A (ja) 糖尿病を有する被験者にガストリン／ｃｃｋ受容体リガンド及びｅｇｆ受容体リガンド組成物を用いた島細胞新生治療方法の効果持続
JP2003535106A (ja) グルコース検知性インスリン誘導体からの、インスリンのグルコース依存性放出
Swope et al. Bombesin stimulates insulin secretion by a pancreatic islet cell line.
Cheung et al. Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line
Duckworth et al. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme
KR20040040482A (ko) 글루카곤-유사 펩타이드 (ｇｌｐ-1) 및 호흡 곤란의 치료
Olbricht et al. Renal hypertrophy in streptozotocin diabetic rats: role of proteolytic lysosomal enzymes
Goodyer et al. Renal tubular cells are potential targets for epidermal growth factor
JP2024511107A (ja) Ｇｉｐとｇｌｐ－１の二重受容体作動薬、医薬組成物および使用
Zucker et al. Effects of the CCK receptor antagonist L364, 718 on pancreatic growth in adult and developing animals
AU2313899A (en) Methods and compositions for treating and diagnosing insulin related disorders
Lazarus et al. Studies on the biological activity of porcine proinsulin
CA1339046C (fr) Proteines possedant les proprietes anaboliques d'une hormone de croissance et exercant un effet reduit sur le metabolisme du carbohydrate
Schäfer et al. Stimulation of (Pro-) insulin biosynthesis and release by gastric inhibitory polypeptide in isolated islets of rat pancreas

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted